SN

Sibani Nepak

Active Director Director DIN 09266173
DIN 09266173 First appointment Aug 2021 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2021
Shareholding value •••• Premium profile

About Sibani Nepak

Data last updated:

Sibani Nepak is a Director at Nepakk Healthcare Private Limited (since 2021). The company operates in Trading. Nepakk Healthcare Private Limited reported revenue of ₹8,448 (FY 2022).

DIN 09266173
Primary Designation Director
Industry Trading
First Appointment 05 Aug 2021
Oldest Company Age 6 yrs
Largest company Nepakk Healthcare Private Limited · ₹8,448 (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nepakk Healthcare Private Limited U51909OR2020PTC033325
Director05 Aug 20212020₹8,448 (FY 2022)Active

Board colleagues of Sibani Nepak

Directorship timeline

Open interactive timeline →
Nepakk Healthcare Private Limited
Premium access

Shareholding and investment profile for Sibani Nepak

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sibani Nepak

Sibani Nepak currently holds 1 directorship: Nepakk Healthcare Private Limited (Director, since 05 Aug 2021, revenue ₹8,448 (FY 2022)).

Sibani Nepak was first appointed on 05 Aug 2021 as Director at Nepakk Healthcare Private Limited.

The current boards of Sibani Nepak's companies include Jalendra Tripathy (Nepakk Healthcare Private Limited), Sanjib Kumar Nepak (Nepakk Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available